Skip to main content
Erschienen in: Supportive Care in Cancer 11/2020

10.02.2020 | Original Article

An analysis of missing items in real-world electronic patient reported outcomes data: implications for clinical care

verfasst von: Heather A. Rosett, Susan C. Locke, Steven P. Wolf, Kris W. Herring, Gregory P. Samsa, Jesse D. Troy, Thomas W. LeBlanc

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Utilization of electronic patient-reported outcomes (ePROs) in the clinic can improve quality of life and prolong survival in cancer care. However, there remain unanswered questions regarding trends in missing data and the potential effect on real-time patient care.

Methods

This study utilized a prospectively collected dataset of ePROs from oncology clinics that administered the Patient Care Monitor 2.0 (PCM), a validated symptoms survey assessing 78 items for men, and 86 for women. We tabulated the frequency of missing items, by item and domain (emotional, functional and physical symptom-related), and examined these by age, gender, education, race and marital status.

Results

Within 20,986 encounters, there were responses to at least 1 PCM item from 6933 unique patients. The highest frequency of missing answers occurred for: “attend a paid job” (10.7%), “reduced sexual enjoyment” (3.8%), and “run” (3.7%). By domain, 12.3% of functional, 8.4% of physical symptom-related, and 1.6% of emotional constructs contained at least one missing item. For functional and physical symptom-related items, missingness was most common in patients >60 years old.

Conclusion

The frequency of missingness was highest for functional items, like attending a paid job, suggesting that some respondents (e.g., retirees without a paid job) skipped questions that were less applicable to them. More universal issues for cancer patients, such as emotional well-being, had much lower frequencies of missingness. This suggests differential item completion that warrants further study to understand the inherent drivers. Identifying causes of missingness could improve the clinical utility of ePROs and highlight opportunities to personalize care.
Literatur
2.
Zurück zum Zitat Abernethy AP, Herndon JE 2nd, Wheeler JL, Day JM, Hood L, Patwardhan M, Shaw H, Lyerly HK (2009) Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/tablet data-collection system in academic oncology. J Pain Symptom Manag 37(6):1027–1038. https://doi.org/10.1016/j.jpainsymman.2008.07.011CrossRef Abernethy AP, Herndon JE 2nd, Wheeler JL, Day JM, Hood L, Patwardhan M, Shaw H, Lyerly HK (2009) Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/tablet data-collection system in academic oncology. J Pain Symptom Manag 37(6):1027–1038. https://​doi.​org/​10.​1016/​j.​jpainsymman.​2008.​07.​011CrossRef
3.
Zurück zum Zitat Pakhomov SV, Jacobsen SJ, Chute CG, Roger VL (2008) Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care 14(8):530–539PubMedPubMedCentral Pakhomov SV, Jacobsen SJ, Chute CG, Roger VL (2008) Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care 14(8):530–539PubMedPubMedCentral
7.
Zurück zum Zitat Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D (2016) Symptom monitoring with patient-reported outcomes during routine Cancer treatment: a randomized controlled trial. J Clin Oncol 34(6):557–565. https://doi.org/10.1200/JCO.2015.63.0830CrossRefPubMed Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D (2016) Symptom monitoring with patient-reported outcomes during routine Cancer treatment: a randomized controlled trial. J Clin Oncol 34(6):557–565. https://​doi.​org/​10.​1200/​JCO.​2015.​63.​0830CrossRefPubMed
12.
Zurück zum Zitat Colsher PL, Wallace RB (1989) Data quality and age: health and psychobehavioral correlates of item nonresponse and inconsistent responses. J Gerontol 44(2):P45–P52CrossRef Colsher PL, Wallace RB (1989) Data quality and age: health and psychobehavioral correlates of item nonresponse and inconsistent responses. J Gerontol 44(2):P45–P52CrossRef
13.
Zurück zum Zitat Huisman M (1999) Item nonresponse: occurrence, causes, and imputation of missing answers to test items Huisman M (1999) Item nonresponse: occurrence, causes, and imputation of missing answers to test items
21.
Zurück zum Zitat Dupont A, Wheeler J, Herndon J, Coan A, Zafar S, Hood L, Patwardhan M, Shaw H, Lyerly H, Abernethy A (2009) Use of tablet personal computers for sensitive patient-reported information. J Support Oncol 7(3):91–97PubMed Dupont A, Wheeler J, Herndon J, Coan A, Zafar S, Hood L, Patwardhan M, Shaw H, Lyerly H, Abernethy A (2009) Use of tablet personal computers for sensitive patient-reported information. J Support Oncol 7(3):91–97PubMed
23.
Zurück zum Zitat LeBlanc TW, Kamal AH (2017) Assessing psychological toxicity and patient-reported distress as the sixth vital sign in cancer care and clinical trials. AMA J Ethics 19(5):460–466CrossRef LeBlanc TW, Kamal AH (2017) Assessing psychological toxicity and patient-reported distress as the sixth vital sign in cancer care and clinical trials. AMA J Ethics 19(5):460–466CrossRef
26.
Zurück zum Zitat Revicki D, Cella D (1997) Health status assessment for the twenty-first century: item response theory, item banking and computer adaptive testing. Qual Life Res 6(6):595–600CrossRef Revicki D, Cella D (1997) Health status assessment for the twenty-first century: item response theory, item banking and computer adaptive testing. Qual Life Res 6(6):595–600CrossRef
27.
Zurück zum Zitat Smith AB, Hanbury A, Retzler J (2019) Item banking and computer-adaptive testing in clinical trials: standing in sight of the PROMISed land. Contemp Clin Trials Commun 13:100306CrossRef Smith AB, Hanbury A, Retzler J (2019) Item banking and computer-adaptive testing in clinical trials: standing in sight of the PROMISed land. Contemp Clin Trials Commun 13:100306CrossRef
28.
Zurück zum Zitat Papuga M, Dasilva C, McIntyre A, Mitten D, Kates S, Baumhauer J (2018) Large-scale clinical implementation of PROMIS computer adaptive testing with direct incorporation into the electronic medical record. Health Syst 7(1):1–12CrossRef Papuga M, Dasilva C, McIntyre A, Mitten D, Kates S, Baumhauer J (2018) Large-scale clinical implementation of PROMIS computer adaptive testing with direct incorporation into the electronic medical record. Health Syst 7(1):1–12CrossRef
30.
Zurück zum Zitat Wagner LI, Schink J, Bass M, Patel S, Diaz MV, Rothrock N, Pearman T, Gershon R, Penedo FJ, Rosen S (2015) Bringing PROMIS to practice: brief and precise symptom screening in ambulatory cancer care. Cancer 121(6):927–934CrossRef Wagner LI, Schink J, Bass M, Patel S, Diaz MV, Rothrock N, Pearman T, Gershon R, Penedo FJ, Rosen S (2015) Bringing PROMIS to practice: brief and precise symptom screening in ambulatory cancer care. Cancer 121(6):927–934CrossRef
Metadaten
Titel
An analysis of missing items in real-world electronic patient reported outcomes data: implications for clinical care
verfasst von
Heather A. Rosett
Susan C. Locke
Steven P. Wolf
Kris W. Herring
Gregory P. Samsa
Jesse D. Troy
Thomas W. LeBlanc
Publikationsdatum
10.02.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05338-8

Weitere Artikel der Ausgabe 11/2020

Supportive Care in Cancer 11/2020 Zur Ausgabe

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.